Fedorova O, Luo M, Jagdmann Jr G, Van Zandt M, Sisto L, Pyle A
ACS Chem Biol. 2025; 20(2):378-385.
PMID: 39824511
PMC: 11851433.
DOI: 10.1021/acschembio.4c00631.
Yildirim I, Andralojc W, Taghavi A, Baranowski D, Gdaniec Z, Kierzek R
Nucleic Acids Res. 2024; 53(1.
PMID: 39711475
PMC: 11724317.
DOI: 10.1093/nar/gkae1222.
Nagasawa R, Onizuka K, Komatsu K, Miyashita E, Murase H, Ojima K
Commun Chem. 2024; 7(1):98.
PMID: 38693284
PMC: 11865577.
DOI: 10.1038/s42004-024-01181-8.
Soliman A, Kodous A, Al-Sherif D, Ghorab M
Future Med Chem. 2024; 16(10):929-948.
PMID: 38661115
PMC: 11221547.
DOI: 10.4155/fmc-2023-0342.
Min Y, Xiong W, Shen W, Liu X, Qi Q, Zhang Y
Sci Adv. 2024; 10(15):eadl4393.
PMID: 38598625
PMC: 11006213.
DOI: 10.1126/sciadv.adl4393.
Advances in machine-learning approaches to RNA-targeted drug design.
Zhou Y, Chen S
Artif Intell Chem. 2024; 2(1).
PMID: 38434217
PMC: 10904028.
DOI: 10.1016/j.aichem.2024.100053.
Computational drug discovery under RNA times.
Bernetti M, Aguti R, Bosio S, Recanatini M, Masetti M, Cavalli A
QRB Discov. 2023; 3:e22.
PMID: 37529286
PMC: 10392680.
DOI: 10.1017/qrd.2022.20.
Fragment-Based Approaches to Identify RNA Binders.
Suresh B, Taghavi A, Childs-Disney J, Disney M
J Med Chem. 2023; 66(10):6523-6541.
PMID: 37186875
PMC: 10825930.
DOI: 10.1021/acs.jmedchem.3c00034.
Targeting Riboswitches with Beta-Axial-Substituted Cobalamins.
Lennon S, Wierzba A, Siwik S, Gryko D, Palmer A, Batey R
ACS Chem Biol. 2023; 18(5):1136-1147.
PMID: 37094176
PMC: 10395008.
DOI: 10.1021/acschembio.2c00939.
Shape selective bifacial recognition of double helical DNA.
Thadke S, Hridya V, Perera J, Gil R, Mukherjee A, Ly D
Commun Chem. 2023; 1.
PMID: 36789151
PMC: 9923363.
DOI: 10.1038/s42004-018-0080-5.
High-throughput single-molecule quantification of individual base stacking energies in nucleic acids.
Abraham Punnoose J, Thomas K, Chandrasekaran A, Vilcapoma J, Hayden A, Kilpatrick K
Nat Commun. 2023; 14(1):631.
PMID: 36746949
PMC: 9902561.
DOI: 10.1038/s41467-023-36373-8.
Inverse In Vitro Selection Enables Comprehensive Analysis of Cross-Chiral L-Aptamer Interactions.
Piwko A, Han X, Kabza A, Dey S, Sczepanski J
Chembiochem. 2022; 23(24):e202200520.
PMID: 36282114
PMC: 9798143.
DOI: 10.1002/cbic.202200520.
SHAPE-enabled fragment-based ligand discovery for RNA.
Zeller M, Favorov O, Li K, Nuthanakanti A, Hussein D, Michaud A
Proc Natl Acad Sci U S A. 2022; 119(20):e2122660119.
PMID: 35561226
PMC: 9171761.
DOI: 10.1073/pnas.2122660119.
Design, synthesis and characterization of novel chromone based-copper(ii) antitumor agents with ,-donor ligands: comparative DNA/RNA binding profile and cytotoxicity.
Arjmand F, Afsan Z, Roisnel T
RSC Adv. 2022; 8(65):37375-37390.
PMID: 35557803
PMC: 9089433.
DOI: 10.1039/c8ra06722h.
RNA-Binding Macrocyclic Peptides.
Pal S, t Hart P
Front Mol Biosci. 2022; 9:883060.
PMID: 35517859
PMC: 9062085.
DOI: 10.3389/fmolb.2022.883060.
PSRR: A Web Server for Predicting the Regulation of miRNAs Expression by Small Molecules.
Yu F, Li B, Sun J, Qi J, De Wilde R, Torres-de la Roche L
Front Mol Biosci. 2022; 9:817294.
PMID: 35386297
PMC: 8979021.
DOI: 10.3389/fmolb.2022.817294.
Expanding the known structure space for RNA binding: a test of 2,5-diketopiperazine.
Arevalo D, Anokhina V, Swart O, Miller B
Org Biomol Chem. 2021; 20(3):606-612.
PMID: 34927652
PMC: 8900054.
DOI: 10.1039/d1ob01976g.
Binding free energy decomposition and multiple unbinding paths of buried ligands in a PreQ1 riboswitch.
Hu G, Zhou H
PLoS Comput Biol. 2021; 17(11):e1009603.
PMID: 34767553
PMC: 8612554.
DOI: 10.1371/journal.pcbi.1009603.
Transcriptome screening followed by integrated physicochemical and structural analyses for investigating RNA-mediated berberine activity.
Satpathi S, Endoh T, Podbevsek P, Plavec J, Sugimoto N
Nucleic Acids Res. 2021; 49(15):8449-8461.
PMID: 33784402
PMC: 8421223.
DOI: 10.1093/nar/gkab189.
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.
Yu A, Choi Y, Tu M
Pharmacol Rev. 2020; 72(4):862-898.
PMID: 32929000
PMC: 7495341.
DOI: 10.1124/pr.120.019554.